NONE
Conditions
Interventions
Experimental group:After undergoing photon rejuvenation therapy, the test samples were used once a day in the morning and once in the evening.
Sponsors
Cosmetics Testing Center, Dermatology Hospital of Southern Medical University
Eligibility
Sex/Gender
Female
Age
20 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Those who have read, understood, and signed the informed consent form. 2. Age range from 20 to 65 years old. 3. Chinese women. 4. The subject self rated as non sensitive skin, Fitzpatrick skin classification II-IV. 5. Suitable for participating in beauty treatments (intense pulsed light therapy), such as subjects with skin diseases such as dullness, uneven skin tone, pigmentation, redness, skin aging, mild acne, and other skin problems. Dermatologists determine the suitability of individuals for cosmetic treatment (intense pulsed light therapy) based on their skin type, medical history, and medication use. 6. Declare good physical condition. 7. Capable of complying with research conditions and willing to follow follow-up arrangements. 8. Agree to avoid excessive exposure to sunlight during the study period, and agree to refrain from using any new cosmetics, toiletries, or personal care products in the study product area. 9. Have the habit of using products of the same type as the research product and/or willing to use the research product. 10. The subjects held a neutral or favorable attitude towards the fragrance of the product during their first visit evaluation.
Exclusion criteria
Exclusion criteria: 1. Pregnant, breastfeeding, or planning to become pregnant during the study period (female only). 2. Have chronic diseases that may interfere with the study (such as asthma, type 1 diabetes, lupus erythematosus, rheumatoid arthritis or other immune/autoimmune diseases). 3. Regularly using or recently using drugs that may mask reactions or interfere with research (such as steroids, antihistamines, singulair, inhaling more than 3 times a month (asthma), anti-rejection or immunosuppressive drugs, insulin). 4. Have been diagnosed with cancer within the past year, have received cancer treatment, or are currently using any cancer prevention medication. 5. The subject has used cosmetics or personal care products that may damage the skin, such as products containing retinoids and acidic components, within the past 3 months. 6. The subject is using products that may damage the skin on a daily basis, such as products with exfoliating, whitening, and other effects. 7. Based on the opinions of the researchers, the subjects have suffered from or currently suffer from skin diseases that may interfere with the study and research results or increase the risk of adverse events (such as eczema, psoriasis, acne rosacea, suspicious skin lesions, severe acne, rash, skin damage, scars, tattoos, sunburned or fever-blister for more than 2 years, cleft lip, stye or chalazion for more than 2 years, seborrheic dermatitis, severe dandruff or skin cancer). 8. Based on the researcher's opinion, the test site has experienced or is currently experiencing any discomfort or signs (including but not limited to burning/stabbing pain, itching, tingling, dryness, tightness, redness, and/or skin damage) within the past week that may interfere with the study and research results products or increase the risk of adverse events. 9. Surgical or cosmetic procedures (such as vision correction) or injections (such as botulinum toxin or fillers) have been performed on the test site within the past 6 months. 10. Plan to perform any surgery during the study period. 11. Respiratory tract, skin or eyes are sensitive to aromatic products. 12. Sensitivity to product replacement or history of allergies/sensitivities/repeated adverse reactions to cosmetics or skin care products. 13. Other research products have been used in the test area within the past 14 days. 14. Research laboratory staff. 15. During the research period, participated in other studies. 16. Before IPL treatment, in the skin assessment, redness is greater than 2 points, edema is greater than 1 point, dryness is greater than 2 points, and/or acne rating is greater than 1 level.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Skin assessment scale ;Adverse event record; | — |
Countries
China
Contacts
Public ContactYang bin
Dermatology Hospital of Southern Medical University
Outcome results
None listed